Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3

JOURNAL ARTICLE published 20 August 2018 in Journal of Clinical Oncology

Authors: Dennis J. Slamon | Patrick Neven | Stephen Chia | Peter A. Fasching | Michelino De Laurentiis | Seock-Ah Im | Katarina Petrakova | Giulia Val Bianchi | Francisco J. Esteva | Miguel Martín | Arnd Nusch | Gabe S. Sonke | Luis De la Cruz-Merino | J. Thaddeus Beck | Xavier Pivot | Gena Vidam | Yingbo Wang | Karen Rodriguez Lorenc | Michelle Miller | Tetiana Taran | Guy Jerusalem